Verano Holdings (VRNO) Deferred Taxes (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Deferred Taxes of -$42000.0 for Q1 2026, down 103.74% year-over-year from $1.1 million in Q1 2025, and down 100.12% quarter-over-quarter from $34.4 million in Q4 2025.
Verano Holdings (VRNO) Deferred Taxes (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Deferred Taxes for 6 consecutive years, with -$42000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Deferred Taxes fell 103.74% year-over-year to -$42000.0; the TTM figure through Mar 2026 stood at $36.3 million (down 66.29% YoY), while the FY2025 annual figure was $37.5 million, down 65.48% from the prior year.
- Deferred Taxes eased to -$42000.0 in Q1 2026 per VRNO's latest filing, from $34.4 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $93.5 million in Q4 2024 and bottomed at -$355000.0 in Q2 2022.
- Historically, Deferred Taxes has averaged $15.1 million across 5 years, with a median of $3.2 million in 2022.
- Annual changes were most pronounced in 2022 — Deferred Taxes jumped 2235.97% — and 2026, when it sank 103.74%.
- Verano Holdings' Deferred Taxes stood at $47.9 million in 2022, then sank by 93.52% to $3.1 million in 2023, then jumped by 2910.66% to $93.5 million in 2024, then sank by 63.23% to $34.4 million in 2025, then tumbled by 100.12% to -$42000.0 in 2026.
- Business Quant data shows VRNO's Deferred Taxes at -$42000.0 in Q1 2026, $34.4 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Verano Holdings | 433.71 Mn | 348.51 Mn | 99.70 Mn | -6.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.72 Mn |
| Mar 31, 2026 | -42,000.00 |
| Dec 31, 2025 | 34.38 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 608,000.00 |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 93.51 Mn |
| Sep 30, 2024 | 7.58 Mn |
| Jun 30, 2024 | 5.46 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Mar 31, 2023 | 3.11 Mn |
| Dec 31, 2022 | 47.94 Mn |
| Sep 30, 2022 | 11.34 Mn |
| Jun 30, 2022 | -355,000.00 |
| Mar 31, 2022 | 3.21 Mn |
| Dec 31, 2021 | 32.81 Mn |
| Sep 30, 2021 | -531,000.00 |